Why the study?
Does clopidogrel cause thrombotic thrombocytopenic purpura?
Does clopidogrel cause thrombotic thrombocytopenic purpura?
Current evidence is insufficient to definitively prove or disprove a causal link between clopidogrel use and TTP.
Answers are grounded in this paper and cite their sources.
Insufficient evidence does not support altering clopidogrel use for TTP risk; leaves open need for definitive studies.
Although the antiplatelet agent clopidogrel is associated with an increased incidence of thrombotic thrombocytopenic purpura (TTP), available evidence is not sufficient to establish or disprove a causal relationship. We review and assess the evidence and case reports linking clopidogrel use with TTP and discuss how to approach the risk of TTP in patients taking clopidogrel.
No takes yet. Share an insight, caveat, or question.
Majhail et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: